• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于采集造血祖细胞的大容量白细胞单采术:CD 34+细胞计数前值在预测成功采集方面的作用

Large volume leukapheresis for collecting hemopoietic progenitors: role of CD 34+ precount in predicting successful collection.

作者信息

Menichella G, Lai M, Serafini R, Pierelli L, Vittori M, Ciarli M, Rumi C, Puggioni P, Scambia G, Sica S, Leone G

机构信息

Catholic University, Rome, Italy.

出版信息

Int J Artif Organs. 1999 May;22(5):334-41.

PMID:10467933
Abstract

In this work we evaluated the efficacy of stem cell collection with Large Volume Procedures. (LVP), and analysed the importance of the CD34+ cell precount in promoting the collection of a sufficient number of CD34+ cells for transplantation, using the Univariate Logistic Regression analysis. Eighty-nine leukapheresis were performed in 49 patients with hematological malignancies and solid tumors, mobilized with chemotherapy plus Granulocyte Colony Stimulating Factor (G-CSF). For each procedure 15.8 liters of blood were processed. The median value of Nucleated Cells (NC) and CD34+ cells precount was respectively 8.29 x 10(9)/ml (range 1.13/45.4) and 43.08 x 103/ml (range 1.06/795.2). Results show the capability of LVP to collect large quantities of hemopoietic progenitors with a median CD34+ cell total yield of 215.02 x 10(6) (range 5.03/2210). The yields per patients' body weight were: CD34+ cells 3.23 x 10(6)/kg (range 0.081/41.58). The regression analysis between blood cell precounts and collection yields gave the following correlations: the CD34+ cell precount correlates with CD34+ yield (r = 0.78 p < 0.00) and with CD34+ cell yield/kg (r = 0.76 p < 0.00). The number of CD34+ cells processed correlated with the number of CD34+ cells collected/kg (r = 0.83 p < 0.000). To investigate the importance of CD 34+ cell precount in promoting CD34+ cell yields > or =2.5 x 10(6)/kg we performed a Univariate Logistic Regression analysis that showed in our patients a probability of collecting > or =2.5 x 10(6) CD34+/kg that rose from 0.6 to 0.95 for CD 34+ precounts that oscillated from 30 to 40 x 10(3) CD34+ cells/ml, respectively. The Univariate Logistic Regression gave a probability of collecting > or =2.5 x 10(6) CD34+ cells/kg that oscillated between 0.64/0.98 for values of CD34+ cells processed from 6 x 10(6)/kg to 8 x 10(6)/kg, p < 0.000. Sixty-three percent of patients reached the target dose of 2.5 x 10(6) CD34+ cells/kg with only one LVP. Until now 12 patients have been transplanted and all have had a prompt and complete lasting recovery. These results confirm the efficacy of LVP in harvesting hemopoietic progenitors and their ability in reconstituting hemopoiesis of transplanted patients, enabling the estimation of CD34+ precounts and CD34+ cells processed values, highly predictive for the collection of > or =2.5 x 10(6) CD34+ cells/kg. Furthermore, the Logistic Model suggests that the best strategy to plan a successful CD34+ cell collection procedure is to identify for each patient the amount of CD34+ cells/kg to be processed rather than the fixed processing of 3/5 blood volumes in all patients.

摘要

在本研究中,我们评估了大容量程序(LVP)采集干细胞的疗效,并使用单变量逻辑回归分析,分析了CD34+细胞预计数在促进采集足够数量的CD34+细胞用于移植方面的重要性。对49例血液系统恶性肿瘤和实体瘤患者进行了89次白细胞单采,这些患者通过化疗加粒细胞集落刺激因子(G-CSF)进行动员。每次程序处理15.8升血液。有核细胞(NC)和CD34+细胞预计数的中位数分别为8.29×10⁹/ml(范围1.13/45.4)和43.08×10³/ml(范围1.06/795.2)。结果显示LVP能够采集大量造血祖细胞,CD34+细胞总产率中位数为215.02×10⁶(范围5.03/2210)。每患者体重的产量为:CD34+细胞3.23×10⁶/kg(范围0.081/41.58)。血细胞预计数与采集产量之间的回归分析得出以下相关性:CD34+细胞预计数与CD34+产量相关(r = 0.78,p < 0.00),与每千克体重CD34+细胞产量相关(r = 0.76,p < 0.00)。处理的CD34+细胞数量与每千克体重采集的CD34+细胞数量相关(r = 0.83,p < 0.000)。为了研究CD34+细胞预计数在促进CD34+细胞产量≥2.5×10⁶/kg方面的重要性,我们进行了单变量逻辑回归分析,结果显示在我们的患者中,对于CD34+预计数在30至40×10³ CD34+细胞/ml之间波动的情况,采集≥2.5×10⁶ CD34+/kg的概率从0.6升至0.95。单变量逻辑回归得出,对于每千克体重处理的CD34+细胞数量在6×10⁶/kg至8×10⁶/kg之间波动的情况,采集≥2.5×10⁶ CD34+细胞/kg的概率在0.64/0.98之间,p < 0.000。63%的患者仅通过一次LVP就达到了2.5×10⁶ CD34+细胞/kg的目标剂量。到目前为止,已有12例患者接受了移植,所有患者均迅速且完全持久地康复。这些结果证实了LVP在采集造血祖细胞方面的疗效及其在重建移植患者造血功能方面的能力,能够估计CD34+预计数和处理的CD34+细胞数量,对采集≥2.5×10⁶ CD34+细胞/kg具有高度预测性。此外,逻辑模型表明,规划成功的CD34+细胞采集程序的最佳策略是为每个患者确定要处理的每千克体重CD34+细胞数量,而不是对所有患者固定处理3/5血容量。

相似文献

1
Large volume leukapheresis for collecting hemopoietic progenitors: role of CD 34+ precount in predicting successful collection.用于采集造血祖细胞的大容量白细胞单采术:CD 34+细胞计数前值在预测成功采集方面的作用
Int J Artif Organs. 1999 May;22(5):334-41.
2
Stem cell collection using the dideco excel continuous flow blood cell separator: parameters for optimal stem cell collection timing.使用迪德科Excel连续流式血细胞分离机进行干细胞采集:优化干细胞采集时机的参数
Int J Artif Organs. 2000 Oct;23(10):703-9.
3
Monitoring of CD34+ cells during leukapheresis allows a single, successful collection of hemopoietic progenitors in patients with low numbers of circulating stem cells.在白细胞单采过程中监测CD34+细胞,可使循环干细胞数量较少的患者单次成功采集造血祖细胞。
Bone Marrow Transplant. 1999 Jun;23(12):1229-36. doi: 10.1038/sj.bmt.1701798.
4
Successful collection and transplantation of peripheral blood stem cells in cancer patients using large-volume leukaphereses.使用大容量白细胞分离术成功采集和移植癌症患者外周血干细胞。
J Clin Apher. 1996;11(4):185-94. doi: 10.1002/(SICI)1098-1101(1996)11:4<185::AID-JCA3>3.0.CO;2-7.
5
Large-volume leukapheresis in pediatric patients: pre-apheresis peripheral blood CD34+ cell count predicts progenitor cell yield.儿科患者的大容量白细胞单采术:单采术前外周血CD34+细胞计数可预测祖细胞产量。
Haematologica. 1999 Jan;84(1):32-5.
6
Factors affecting hemopoietic recovery after high-dose therapy and autologous peripheral blood progenitor cell transplantation: a single center experience.大剂量治疗及自体外周血祖细胞移植后影响造血恢复的因素:单中心经验
Haematologica. 1998 Apr;83(4):329-37.
7
Predictive factors for peripheral-blood progenitor-cell collections using a single large-volume leukapheresis after cyclophosphamide and granulocyte-macrophage colony-stimulating factor mobilization.环磷酰胺和粒细胞巨噬细胞集落刺激因子动员后采用单次大容量白细胞分离术进行外周血祖细胞采集的预测因素
J Clin Oncol. 1995 Mar;13(3):705-14. doi: 10.1200/JCO.1995.13.3.705.
8
Recruitment of CD34+ cells during large-volume leukapheresis.大容量白细胞单采过程中CD34+细胞的募集
J Hematother Stem Cell Res. 2001 Dec;10(6):837-53. doi: 10.1089/152581601317210935.
9
CD34+ cell mobilization for allogeneic progenitor cell transplantation: efficacy of a short course of G-CSF.用于异基因祖细胞移植的CD34+细胞动员:短疗程粒细胞集落刺激因子的疗效
Transfusion. 2001 Feb;41(2):190-5. doi: 10.1046/j.1537-2995.2001.41020190.x.
10
Optimising parameters for peripheral blood leukapheresis after r-metHuG-CSF (filgrastim) and r-metHuSCF (ancestim) in patients with multiple myeloma: a temporal analysis of CD34(+) absolute counts and subsets.优化多发性骨髓瘤患者使用重组人粒细胞集落刺激因子(非格司亭)和重组人干细胞因子(阿伐司亭)后外周血白细胞单采的参数:CD34(+)绝对计数及亚群的时间分析
Bone Marrow Transplant. 2002 Dec;30(12):851-60. doi: 10.1038/sj.bmt.1703765.

引用本文的文献

1
Regenerative Medicine of Liver: Promises, Advances and Challenges.肝脏再生医学:前景、进展与挑战
Biomimetics (Basel). 2021 Oct 20;6(4):62. doi: 10.3390/biomimetics6040062.
2
Current Perspectives Regarding Stem Cell-Based Therapy for Liver Cirrhosis.基于干细胞的肝硬化学治疗的当前观点。
Can J Gastroenterol Hepatol. 2018 Jan 29;2018:4197857. doi: 10.1155/2018/4197857. eCollection 2018.
3
Hematopoietic stem and progenitor cell harvesting: technical advances and clinical utility.造血干细胞和祖细胞采集:技术进展与临床应用
J Blood Med. 2015 Feb 18;6:55-67. doi: 10.2147/JBM.S52783. eCollection 2015.
4
Bone marrow-derived stromal cell therapy in cirrhosis: clinical evidence, cellular mechanisms, and implications for the treatment of hepatocellular carcinoma.骨髓基质细胞疗法治疗肝硬化:临床证据、细胞机制以及对肝细胞癌治疗的影响。
Int J Radiat Oncol Biol Phys. 2014 Jul 15;89(4):786-803. doi: 10.1016/j.ijrobp.2014.02.017.
5
Adult stem cells and their trans-differentiation potential--perspectives and therapeutic applications.成体干细胞及其转分化潜能——观点与治疗应用
J Mol Med (Berl). 2008 Dec;86(12):1301-14. doi: 10.1007/s00109-008-0383-6. Epub 2008 Jul 16.